the FDA make that determination when the re-submission is made by Mesoblast.
but we can clearly see this is a class 2 CRL... they are asking for another trial.
Not something we can whip up in a couple of weeks and resubmit. the new trial they want could take a long time to recruit, especially if they want kids in a RCT... it may not even be possible.
MSB to dispute FDA finding in Type A meeting, page-195
-
- There are more pages in this discussion • 823 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.17 | $1.15 | $506.3K | 436.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20624 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 35509 | 6 |
View Market Depth
| Last trade - 10.22am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |